These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28281210)

  • 21. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets].
    Liang XD; Zheng Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):559-64. PubMed ID: 20957015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrophilic excipients modulate the time lag of time-controlled disintegrating press-coated tablets.
    Lin SY; Li MJ; Lin KH
    AAPS PharmSciTech; 2004 Aug; 5(4):e54. PubMed ID: 15760051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluations of a novel pulsed and controlled osmotic pump capsule.
    Zhang W; Zhang L; Qu X; Zhu Z; Pan Y; Guan J; Pan W
    Drug Dev Ind Pharm; 2015 Feb; 41(2):322-32. PubMed ID: 24295490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
    Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
    Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and process optimization of multiparticulate pulsatile system delivered by osmotic pressure-activated rupturable membrane.
    Hung SF; Hsieh CM; Chen YC; Lin CM; Ho HO; Sheu MT
    Int J Pharm; 2015 Mar; 480(1-2):15-26. PubMed ID: 25575473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora ; Malik K; Rana V; Singh I
    Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of sinomenine hydrochloride delayed-onset sustained-release tablets].
    Zhang Y; Geng Y
    Zhongguo Zhong Yao Za Zhi; 2010 Mar; 35(6):703-7. PubMed ID: 20545191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aqueous Polymer Dispersion Coating Used for Osmotic Pump Tablets: Membrane Property Investigation and IVIVC Evaluation.
    Cheng L; Gai X; Wen H; Liu D; Tang X; Wang Y; Wang T; Pan W; Yang X
    AAPS PharmSciTech; 2018 Jan; 19(1):242-250. PubMed ID: 28695327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
    Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
    Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
    Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimetazidine Dihydrochloride Pulsatile-Release Tablets for the Treatment of Morning Anginal Symptoms: Dual Optimization, Characterization and Pharmacokinetic Evaluation.
    Othman AI; Amin MM; Abu-Elyazid SK; Abdelbary GA
    Curr Drug Deliv; 2021; 18(8):1182-1196. PubMed ID: 33583377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel approach to sustained pseudoephedrine release: differentially coated mini-tablets in HPMC capsules.
    Ishida M; Abe K; Hashizume M; Kawamura M
    Int J Pharm; 2008 Jul; 359(1-2):46-52. PubMed ID: 18467046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.